Harnessing chromium in the fight against diabetes

Drug Discovery Today

Volumn 8, Issue 21, 2003, Pages 962-963

  Brown, Matt ^a  

^a NONE

Author keywords

Biochemistry; Cell biology; Chromium; Diabetes; Diet; Drug Discovery; Glucose; Pharmaceutical Science; Supplement

Indexed keywords

CHROMIUM PICOLINATE; GLUCOSE; INSULIN; PLACEBO; PROTEIN KINASE B; SULFONYLUREA;

BLINDNESS; DIABETES MELLITUS; DIET; DIET SUPPLEMENTATION; ETIOLOGY; EXERCISE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART DISEASE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; NOTE; PROTEIN PHOSPHORYLATION; SIDE EFFECT; SKELETAL MUSCLE; SYMPTOMATOLOGY;

EID: 0344552281     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02892-7     Document Type: Short Survey

References (4)

1. Anderson R.A., et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 46:1997;1786-1791.
2. Cefalu W.T., et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem. Exp. Med. 12:1999;71-83.
3. Anderson R.A. Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17:1998;548-555.
4. Cefalu, W.T. et al. (2003) Chromium picolinate supplementation increases insulin-stimulated Akt phosphorylation in vivo in skeletal muscle from subjects with Type 2 diabetes. 18th International Diabetes Federation Congress 24-29 August, Paris, France (Abstract No. 154).